IBM Q3: A Beat On Everything, Except For Guidance (NYSE:IBM)
IBM Q3: A Beat On Everything, Except For Guidance (NYSE:IBM) Seeking Alpha
Covered in this story
Analyst targets on IBM
- Morgan Stanley: $234 → $238 by Oct 2027 · Equal-Weight via MarketBeat
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 51 stories mentioning IBM, the earliest published 20 Oct 2026.
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.